Brainomix

Company Overview

Since launching as a University of Oxford spin-out in 2010, Brainomix have developed award-winning AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. 

Brainomix drives improvement in patient outcomes by enhancing doctors’ decisions and working with pharmaceutical companies to translate treatments into clinical practice.

Brainomix 360 Stroke is a comprehensive AI imaging suite of solutions that supports clinicians to make faster, more confident treatment decisions from any imaging modality in the acute stroke pathway.

Modalities